Literature DB >> 19758401

Angiotensin receptors in the eyes of arterial hypertensive rats.

Anu Vaajanen1, Päivi Lakkisto, Ismo Virtanen, Esko Kankuri, Olli Oksala, Heikki Vapaatalo, Ilkka Tikkanen.   

Abstract

PURPOSE: The aim of the present study was to determine whether the eye tissues of arterial hypertensive rats evince expression of angiotensin receptors (AT(1) and AT(2)) as well as the novel Mas receptor, whose endogenous ligand is vasorelaxing Angiotensin (1-7) [Ang (1-7)].
METHODS: Enucleated eyes from spontaneously hypertensive rats (SHR) and double transgenic rats harbouring human renin and angiotensinogen genes (dTGR) and their normotensive controls were used. Half of the rats were pretreated orally with an Angiotensin II (Ang II) type 1 receptor blocker (ARB). The eyes were snap-frozen in isopentane at -40 degrees and stored at -70 degrees for subsequent reverse transcriptase polymerase chain reaction (RT-PCR) analysis or in vitro autoradiography.
RESULTS: The mRNA expression of AT(1a) and AT(2) as well as the novel Mas receptor was detected in all rat groups, being markedly higher in the retina than in the ciliary body. dTGR had significantly more receptors than SHR, but no direct relation to blood pressure level was seen. According to the autoradiography, treatment with ARB blocked a part of AT(1) receptors but had no clear effect on AT(2) receptors.
CONCLUSION: The novel Mas receptor was found by RT-PCR in eye tissue for the first time. Its specific ligand, Ang (1-7), may be involved in the regulation of intraocular pressure--as recently demonstrated by us--and in the pathogenesis of retinal diseases as a counter-regulatory component for the vascular and proliferative actions of Ang II. The results suggest that the density of AT(1) receptors in the eye is independent of the blood pressure level of the animal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19758401     DOI: 10.1111/j.1755-3768.2009.01563.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  11 in total

1.  Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice.

Authors:  Yiguo Qiu; Pollob Kumar Shil; Ping Zhu; Hongxia Yang; Amrisha Verma; Bo Lei; Qiuhong Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-22       Impact factor: 4.799

Review 2.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

3.  Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2.

Authors:  Giselle Foureaux; José C Nogueira; Bárbara S Nogueira; Gustavo O Fulgêncio; Gustavo B Menezes; Simone O A Fernandes; Valbert N Cardoso; Renata S Fernandes; Gabriel P Oliveira; Juçara R Franca; André A G Faraco; Mohan K Raizada; Anderson J Ferreira
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-21       Impact factor: 4.799

4.  Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats.

Authors:  Giselle Foureaux; Juçara Ribeiro Franca; José Carlos Nogueira; Gustavo de Oliveira Fulgêncio; Tatiana Gomes Ribeiro; Rachel Oliveira Castilho; Maria Irene Yoshida; Leonardo Lima Fuscaldi; Simone Odília Antunes Fernandes; Valbert Nascimento Cardoso; Sebastião Cronemberger; André Augusto Gomes Faraco; Anderson José Ferreira
Journal:  PLoS One       Date:  2015-07-23       Impact factor: 3.240

5.  Activation of endogenous angiotensin converting enzyme 2 prevents early injuries induced by hyperglycemia in rat retina.

Authors:  G Foureaux; B S Nogueira; D C O Coutinho; M K Raizada; J C Nogueira; A J Ferreira
Journal:  Braz J Med Biol Res       Date:  2015-09-29       Impact factor: 2.590

6.  The expression of Mas-receptor of the renin-angiotensin system in the human eye.

Authors:  A Vaajanen; G Kalesnykas; H Vapaatalo; H Uusitalo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-14       Impact factor: 3.117

7.  Topical administration of diminazene aceturate decreases inflammation in endotoxin-induced uveitis.

Authors:  Changwei Zheng; Chunyan Lei; Zihe Chen; Shijie Zheng; Hongxia Yang; Yiguo Qiu; Bo Lei
Journal:  Mol Vis       Date:  2015-04-10       Impact factor: 2.367

8.  Expression and cellular localization of the Mas receptor in the adult and developing mouse retina.

Authors:  Tuhina Prasad; Amrisha Verma; Qiuhong Li
Journal:  Mol Vis       Date:  2014-10-17       Impact factor: 2.367

9.  AAV8-Mediated Angiotensin-Converting Enzyme 2 Gene Delivery Prevents Experimental Autoimmune Uveitis by Regulating MAPK, NF-κB and STAT3 Pathways.

Authors:  Yiguo Qiu; Lifei Tao; Shijie Zheng; Ru Lin; Xinyu Fu; Zihe Chen; Chunyan Lei; Jiaming Wang; Hongwei Li; Qiuhong Li; Bo Lei
Journal:  Sci Rep       Date:  2016-08-25       Impact factor: 4.379

Review 10.  Therapeutic targets of renin-angiotensin system in ocular disorders.

Authors:  Rajesh Choudhary; Mandeep Singh Kapoor; Amrita Singh; Surendra H Bodakhe
Journal:  J Curr Ophthalmol       Date:  2016-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.